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ABSTRACT Lung surfactant (LS) and albumin compete for the air-water interface when both are present in solution. Equilib-
rium favors LS because it has a lower equilibrium surface pressure, but the smaller albumin is kinetically favored by faster diffu-
sion. Albumin at the interface creates an energy barrier to subsequent LS adsorption that can be overcome by the depletion
attraction induced by polyethylene glycol (PEG) in solution. A combination of grazing incidence x-ray diffraction (GIXD), x-ray
reﬂectivity (XR), and pressure-area isotherms provides molecular-resolution information on the location and conﬁguration of
LS, albumin, and polymer. XR shows an average electron density similar to that of albumin at low surface pressures, whereas
GIXD shows a heterogeneous interface with coexisting LS and albumin domains at higher surface pressures. Albumin induces
a slightly larger lattice spacing and greater molecular tilt, similar in effect to a small decrease in the surface pressure. XR shows
that adding PEG to the LS-albumin subphase restores the characteristic LS electron density proﬁle at the interface, and conﬁrms
that PEG is depleted near the interface. GIXD shows the same LS Bragg peaks and Bragg rods as on a pristine interface, but with
a more compact lattice corresponding to a small increase in the surface pressure. These results conﬁrm that albumin adsorption
creates a physical barrier that inhibits LS adsorption, and that PEG in the subphase generates a depletion attraction between the
LS aggregates and the interface that enhances LS adsorption without substantially altering the structure or properties of the LS
monolayer.doi: 10.1016/j.bpj.2009.05.017INTRODUCTION
Adsorption of lung surfactants (LS) and many soluble
proteins to the air-water interface occurs spontaneously
because adsorption lowers the interfacial energy. The surface
pressure, P, is the negative derivative of the free energy, G,
with respect to the interfacial area, A: P ¼ ðvG
vAÞn. (1).
The higher equilibrium surface pressure of LS (~45 mN/m
(2)) compared with albumin (~20 mN/m (3)) suggests that
LS should adsorb preferentially to albumin at an air-water
interface. However, equilibrium says nothing about the rela-
tive adsorption rates. The rate of albumin adsorption from
solution is favored by its nanometer size and subsequent
faster diffusion compared with the multimicron bilayer lipo-
somes of LS. In both the Langmuir trough and the expanding
alveolus in the lung, a new air-water interface is continu-
ously being created for this competitive adsorption. In addi-
tion to this new interface, for equilibrium to occur, LS must
displace albumin from whatever part of the interface it
occupies. However, LS adsorption, although favored ener-
getically, does not occur for hours (if at all) when albumin
is in the subphase or already occupies the interface (2,4).
The transport of LS to the interface is inhibited by albumin
at the interface, likely because of the energy barrier induced
by the electrostatic and steric interactions between the
anionic LS and the negatively charged albumin (4). This
energy barrier to LS adsorption is directly analogous to the
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prevents them from flocculating (2,4–10). We and others
(2,4–10) have found that oppositely charged polyelectrolytes
and divalent ions, uncharged hydrophilic polymers, and
increased total electrolyte concentration, all of which
promote colloid flocculation, also promote LS displacement
of albumin at interfaces.
One well-established method of flocculating colloids that
also promotes surfactant adsorption is to add hydrophilic
polymers, such as polyethylene glycol (PEG), to the surfac-
tant dispersion (2,11,12). In analogy to their effects on
colloids, polymers induce a ‘‘depletion attraction’’ between
LS liposomes in solution and the interface (4,6,7). However,
for the depletion attraction to exist, PEG must not adsorb to
LS, albumin, or the air-water interface, i.e., there must be an
excluded volume near the interface that the polymer is pre-
vented from exploring. In previous work, we showed that
the scaling of polymer concentration (6) and molecular
weight (7) needed to restore surfactant adsorption is consis-
tent with that predicted by the depletion attraction/energy
barrier model (4). However, the molecular signatures of
the depletion attraction require higher-resolution information
from x-ray reflectivity (XR) (13,14) and grazing incidence
x-ray diffraction (GIXD) to determine the location and orga-
nization of surfactant, protein, and polymer.
XR shows that when both Survanta (a clinical LS) and
albumin are in the subphase, albumin dominates the inter-
face. However, GIXD shows that small patches of LS coexist
with the albumin, depending on the surface pressure. Adding
778 Stenger et al.PEG to the subphase restores the characteristic LS isotherm
even though albumin is also in the subphase. With PEG, the
average electron density and Bragg peaks are similar to those
of Survanta on a pristine subphase, confirming that the Sur-
vanta has displaced the albumin at the interface. XR also
shows that PEG is depleted from the interface, consistent
with the depletion attraction mechanism. It was previously
suggested that albumin and/or PEG might alter the molecular
ordering of an LS film at the air-water interface (15), result-
ing in a hybrid surfactant/albumin mixed film at the air-water
interface (10,15,16). However, GIXD shows that the molec-
ular organization of the ordered fraction of the Survanta film
is substantially unchanged by PEG or albumin at all surface
pressures, although GIXD cannot address the molecular
organization of the disordered fraction of the monolayer.
MATERIALS AND METHODS
Survanta is a clinical replacement LS prepared by organic extraction of
minced bovine lungs (Abbott Laboratories, Columbus, OH) (17) and was
a generous gift of the Santa Barbara Cottage Hospital nursery. NaCl,
CaCl2, NaHCO3, 10 kDa PEG, and bovine serum albumin were obtained
from Sigma (St. Louis, MO) and used as received. All water used in exper-
iments had a resistivity of 18.2 MU-cm (Millipore gradient system; Milli-
pore, Billerica, MA). All synchrotron x-ray measurements were carried
out using the liquid surface diffractometer at the BW1 (undulator) beam
line at the Hamburg Synchrotron Radiation Laboratory, German Electron
Synchrotron (Hamburg, Germany). The theory of XR and GIXD has been
presented in detail elsewhere (13,18,19) and the scattering geometries
used have also been illustrated previously (19,20). A temperature-controlled
Langmuir trough equipped with a Wilhelmy plate and motorized barrier was
mounted on the diffractometer and maintained at 20C. After the samples
were prepared, but before x-ray data were collected, helium was flushed
through the trough enclosure for at least 40 min to reduce the scattering back-
ground and to minimize beam damage during x-ray scans. The oxygen level
was constantlymonitored to be<2%.The synchrotronx-ray beamwasmono-
chromated to a wavelength of l ~1.304 A˚ by Bragg reflection from a Beryl-
lium (200) monochromator crystal in the Laue geometry. To initiate each
experiment, an albumin and/or polymer containing buffer (150 mM NaCl,
2 mM CaCl2, 0.2 mM NaHCO3, pH 7) in the Langmuir trough was allowed
to equilibrate for 10 min; for albumin-containing subphases, P increased to
~18 mN/m. Survanta was diluted in the same buffer to a lipid concentration
of 2 mg/mL and deposited as microliter drops from a syringe by touching
the drop to the air-water interface of the open trough. The subphase was not
stirred, and the first compression began 20 min after deposition.
For GIXD, the x-ray beam is configured to strike the surface at an incident
angle of 0.11, which corresponds to qz¼ 0.85 qc, where qc¼ 0.0219 A˚1 is
the critical scattering vector for total external reflection from the subphase.
At this angle, the incident wave is totally reflected, whereas the refracted
wave is an evanescent wave traveling along the liquid surface. Such a config-
uration maximizes surface sensitivity. The dimension of the x-ray beam
footprint on the liquid surface was ~2 mm 50 mm. For in-plane diffraction
measurements, a Soller collimator (JJ X-ray, Liseleje, Denmark) consisting
of closely spaced vertical plates was placed before a vertical, one-dimen-
sional, position-sensitive detector with vertical acceptance 0 < qz <
1.2 A˚1, yielding a lateral resolution of Dqxy¼ 0.0084 A˚1. As a precaution
against beam damage, the trough was translated perpendicular to the x-ray
beam at every step of the qxy scan. The Origin Peak Fitting Module (North-
ampton, MA) was used to fit the Bragg peaks. After the number of peaks was
specified, the fit with the lowest c2 was chosen. GIXD provides information
only about ordered domains within the monolayer; disordered regions do not
diffract appreciably (19).Biophysical Journal 97(3) 777–786The reflectivity, R, is defined as the ratio of the intensity of x rays spec-
ularly reflected from a surface relative to that of the incident x-ray beam.
When measured as a function of wave-vector transfer (qz ¼ jkout  kinj ¼
4psina/l, where a is the grazing angle and l is the wavelength of the
x-ray beam), the reflectivity curve contains information on the sample-
normal profile of the in-plane average of the electron density. Reflectivities
with qz values from 0.01 to 0.8 A˚
1 were measured using an NaI scintillation
detector, and reasonable statistics were obtained for values of R R 1010.
Typical scanning times for this qz range were 30 min. As a precaution against
beam damage, the sample was regularly translated for the full 2-mmwidth of
the beam. Remeasuring part of the reflectivity curve before and after trans-
lation afforded a check of the reproducibility. The absolute reflectivity was
derived by subtracting the measured background, followed by normalization
to the incident beam flux. The data were plotted as R/RF versus the perpen-
dicular scattering vector, qz. The error bars on the data represent the statis-
tical errors in the measurements (standard deviation, 5sR). The measured
reflectivity curves were analyzed using a model-free approach (21–23) to
obtain detailed information on the electron density distribution in the direc-
tion normal to the interface. Increasing z represents moving from the air
through the monolayer and into the subphase. For comparison, all electron
density curves were aligned vertically at the tailgroup inflection point, which
was set at z ¼ 7.7 A˚.
RESULTS
GIXD
Fig. 1 shows the Bragg peaks (Fig. 1 a) and Bragg rods
(Fig. 1 b) from a Survanta film on the control subphase. At
20 mN/m, two Bragg peaks are present, with the integrated
intensity of the qxy ¼ 1.44 A˚1 or {1,0} peak roughly twice
that of the qxy ¼ 1.48 A˚1 or {1,1} peak, indicating a dis-
torted hexagonal lattice similar to DPPC and DPPC/palmitic
acid (PA) mixtures under similar conditions (24,25). The
measured lattice spacings (dxy ¼ 2p/qxy), d10 ¼ 4.38 A˚
and d11 ¼ 4.24 A˚, correspond to a distorted hexagonal unit
cell with axes aH ¼ 4.95 A˚ and angle g¼118. The area
per hydrocarbon chain (phospholipids are composed of
two alkyl chains and PA of one alkyl chain per molecule,
respectively) is 21.7 A˚2, similar to DPPC, DPPC/PA
(24,25), and previous measurements of Survanta (26). The
Bragg rod profile (Fig. 1 b) exhibits a local maximum at
qz ¼ 0.41 A˚1, indicating that the lipid molecules are tilted
relative to the surface normal (26).
Increasing the surface pressure to 30 mN/m causes the two
Bragg peaks to shift to q10 ¼ 1.47 A˚1 and q11 ¼ 1.49 A˚1
indicating a more compact distorted hexagonal lattice. The
Bragg rod profile exhibits a local maximum at qz¼ 0.23 A˚1,
indicating a reduction in lipid tilt with increasing surface pres-
sure commensurate with the smaller area per hydrocarbon
chain (25). At 40 mN/m, the single peak at q10 ¼ 1.49 A˚1
indicates a transition to an untilted hexagonal lattice with
d10¼ 4.21 A˚ and aH¼ 4.86 A˚. The Bragg rod shows no local
maximum, indicating that the lipid molecules are normal to
the interface. In addition to the main peak, there is a small
peak at qxy¼ 1.42 A˚1 forPR 40mN/m,which likely corre-
sponds to a minor fraction of a second crystalline phase (26).
The origin of this second phase is unknown; Survanta
contains small fractions of saturated lipids in addition to
GIXD/XR Study of Surfactant Inhibition and Reversal 779FIGURE 1 Bragg peaks and rods from GIXD of 200 mg
Survanta spread onto a saline buffer subphase. (a) Bragg
peaks at 20–50 mN/m. (b) Bragg rods at 20–50 mN/m.DPPC capable of forming crystalline phases (17). Increasing
the surface pressure to 50mN/m results in only a slight shift of
themain peak to qxy¼ 1.50 A˚1; the Bragg rods again indicate
that the molecules are untilted. In contrast to the well-defined
lattice of Survanta films, GIXD scans of subphases containing
2 mg/mL albumin, 5% wt. PEG, or mixtures of albumin and
PEG, lack the Bragg peaks indicative of long-range order
over the qxy ranges for phospholipid films or proteins (data
not shown).
Fig. 2 shows the Bragg peaks (Fig. 2 a) and Bragg rods
(Fig. 2 b) from GIXD of Survanta on a subphase containing
5% wt. PEG. For P ¼ 25 mN/m (with PEG, the minimum
surface pressure of the Survanta film was > 20 mN/m;
Fig. 1 c), the two Bragg peaks with q10 ¼ 1.44 A˚1 and
q11 ¼ 1.48 A˚1 with a 2:1 integrated intensity are identical
to the distorted hexagonal lattice of Survanta on the control
subphase. The Bragg rod profile exhibits a local maximum
at qz ¼ 0.41 A˚1, indicating that the lipid molecules are
tilted. At P ¼ 30 mN/m, the two Bragg peaks shift right
to q10 ¼ 1.45 A˚1 and q11 ¼ 1.49 A˚1 and the Bragg rod
maxima moves to qz ¼ 0.35 A˚1, indicating a reduction intilt and a more compact lattice. At 40 mN/m, a single peak
is present at q10¼ 1.50 A˚1, indicating a transition to hexag-
onal packing. The Bragg rod at q10 ¼ 1.50 A˚1 shows no
local maximum, indicating that the molecules are normal
to the interface. As was the case for Survanta with no
PEG, a smaller peak occurs at qxy ¼ 1.42 A˚1, indicative
of a second crystalline phase. The peak positions at q10 ¼
1.50 A˚1 and qxy ¼ 1.42 A˚1 are unchanged at 50 mN/m.
Fig. 3 shows the Bragg peaks from GIXD scans of 600 mg
Survanta spread on a 2 mg/mL albumin subphase (see the
Supporting Material). At P ¼ 20 mN/m, different areas of
the interface showed different scattering. Region 1 (top
panel) shows no diffraction peaks consistent with albumin
at the interface. However, region 2 (second panel, obtained
by moving the sample horizontally by several millimeters in
the direction perpendicular to the beam) shows diffraction
peaks consistent with a distorted hexagonal lattice with
q10 ¼ 1.39 A˚1 and q11¼ 1.47 A˚1. The lattice is somewhat
expanded compared to Survanta at 20mN/mwith aH¼ 5.04 A˚
and g¼116. The Bragg rods (not shown) exhibit a local
maximum at qz ¼ 0.57 A˚1, indicating a greater molecularFIGURE 2 Bragg peaks and rods from GIXD of 200 mg Sur-
vanta spread onto a saline buffer subphase containing 5% wt.
PEG. (a) Bragg peaks at 25–50 mN/m (The minimum surface
pressure was ~25 mN/m on the PEG subphase. (b) Bragg rods
at 25–50 mN/m. Both the Bragg peaks and rods are similar to
those of Survanta on the control subphase.Biophysical Journal 97(3) 777–786
780 Stenger et al.tilt than Survanta on the control subphase (Fig. 1 b). The
diffraction peaks demonstrate that some ordered domains of
Survanta are present at the interface. Increasing the surface
pressure to the maximum sustainable under these conditions
(28 mN/m), causes the two peaks to shift to q10 ¼ 1.44 A˚1
and q11 ¼ 1.48 A˚1, corresponding to a less tilted and more
compact distorted hexagonal lattice. The local maximum at
qz¼ 0.37 A˚1 indicates a greater molecular tilt than Survanta
on the control subphase at the same surface pressure (see
Table 1). As the tilt and the lattice spacing of Survanta and
other lipids increases with decreasing surface pressure
(14,24–27), the albumin acts as if it were lowering the effec-
tive surface pressure that the Survanta experiences. The last
panel in Fig. 3 shows GIXD scans after two additional
compression-expansion cycles; the Bragg peaks can no
longer be found, indicting that no ordered domains of Sur-
vanta remain at the interface.
Bragg peaks (Fig. 4) from GIXD scans of 600 mg Survanta
spread on a subphase with 2 mg/mL albumin and 5% wt.
FIGURE 3 Bragg peaks from GIXD of 600 mg Survanta spread onto
a saline buffer subphase containing 2 mg/mL albumin. The first two panels
show different regions of the film at the same surface pressure. The top panel
shows no Bragg peaks in region 1, consistent with an albumin-covered inter-
face. The second panel shows that in the adjacent region (region 2), Bragg
peaks reveal the presence of Survanta. The third panel shows that the Sur-
vanta lattice compacts with increasing surface pressure; however, surface
pressures higher than 28 mN/m could be sustained due to the presence of
albumin. The last panel shows GIXD at 20 mN/m after two additional
cycles; the Survanta peaks are no longer present.Biophysical Journal 97(3) 777–786PEG confirm the adsorption of Survanta. Before the Sur-
vanta was spread, the surface pressure was ~18 mN/m, indi-
cating albumin had adsorbed to the interface. However, after
the Survanta was spread, the characteristic Survanta diffrac-
tion peaks were observed everywhere on the interface. At
20 mN/m, q10 ¼ 1.48 A˚1 and q11 ¼ 1.49 A˚1; the Bragg
rods have a local maximum at qz ¼ 0.09 A˚1 (not shown).
Compared to Survanta at 20 mN/m, the PEG in the subphase
condenses the Survanta lattice and reduces the tilt. By
30 mN/m, the lattice has further condensed with q10 ¼
1.50 A˚1 and qz ¼ 0 A˚1, indicating that the molecules
are hexagonally packed and normal to the interface. At
40 mN/m, the main peak remains at qxy ¼ 1.50 A˚1 and a
smaller peak remains at qxy ¼ 1.45 A˚1, indicating that a
second crystalline phase is also present. This second phase
is shifted compared to Survanta at 40 mN/m, indicating
a slightly tighter packing due to the effects of the PEG. The
Bragg rods showno localmaximum (qz¼ 0 A˚1) at 40mN/m,
indicating that the molecules are normal to the interface.
X-ray reﬂectivity
XR provides an averaged electron density profile normal to
the interface of all lipid and protein components, which
complements the in-plane information from GIXD. Fig. 5 a
shows the reflectivity, R, scaled by the Fresnel reflectivity,
RF, for Survanta spread on the control subphase; the corre-
sponding electron density profiles, normalized by the
subphase electron density (r(z)/rsub) are shown in Fig. 5 b
(21–23). (The double cusp of R/RF near qz ¼ 0.02 A˚1 is
a visual artifact that comes from dividing the measured
R(qz), which is affected by finite resolution by the ideally
calculated Fresnel law RF(qz)). For the Survanta films, the
electron density begins at 0 on the air side of the interface
(z ¼ 0), rises sharply through the tail region, and reaches
a maximum at the headgroup region at z ~ 30 A˚ before
quickly decaying to the subphase electron density (r(z)/
rsub ¼ 1) at z ~ 42 A˚. All data sets were fit over a z range
from 0 to 140 A˚ to facilitate comparisons between samples.
Care was taken to ensure that increasing the range of z did
not significantly change the c2 of the fit or the shape of the
electron density curves for the electron density profiles that
did not contain albumin and did not show deviations from
the water electron density for z > 50 A˚. The density of the
headgroup maximum increases (from 1.17 to 1.22) and the
width of the maximum decreases and shifts to the right
with increasing surface pressure, indicating a reduction in
the tilt of the tails, consistent with the Bragg rods in Fig. 1
and previous XR of DPPC monolayers (29).
Fig. 6, a and b, show XR and electron density profiles for
a 2 mg/mL albumin-containing subphase as well as 600 mg
Survanta spread on the albumin subphase. The electron
density at the interface increases more sharply than does Sur-
vanta on the control subphase (Fig. 5 b), reaching amaximum
r/rsub ¼ 1.25 at z ¼ 15 A˚. Unlike the electron density
GIXD/XR Study of Surfactant Inhibition and Reversal 781TABLE 1 Survanta d-spacings, unit cell parameters, coherence length, and area per chain as a function of subphase composition
and surface pressure
Phase 1 Phase 2
Subphase p, mN/m Packing
Observed
d-spacing
d10 (A˚)
Observed
d-spacing
d1-1 (A˚)
Unit
cell a¼b (A˚) Angle a
Coherence
length
Lc10 (A˚)
Coherence
length
Lc1-1 (A˚)
Area per
chain (A2)
Observed
d-spacing
d10 (A˚)
Unit
cell a ¼ b (A˚)
Saline buffer 20 Dist. Hex 4.38 4.24 4.95 118 100 175 21.7 — -
Saline buffer 30 Dist. Hex 4.29 4.22 4.90 119 115 265 21.0 4.43 5.12
Saline buffer 40 Hexagonal 4.21 — 4.86 120 177 — 20.5 4.43 5.12
Saline buffer 50 Hexagonal 4.19 — 4.84 120 185 — 20.3 4.43 5.12
PEG 25 Dist. Hex 4.36 4.23 4.94 118 129 225 21.5 4.58 5.29
PEG 30 Dist. Hex 4.32 4.22 4.91 118 131 237 21.2 4.58 5.29
PEG* 40a Hexagonal 4.18 — 4.83 120 287 — 20.2 4.42 5.10
PEG* 40 Hexagonal 4.19 — 4.83 120 200 — 20.2 4.42 5.10
PEG 50 Hexagonal 4.20 — 4.84 120 181 — 20.3 4.41 5.09
Albumin 20 Dist. Hex 4.53 4.28 5.04 116 64 296 22.8 — —
Albumin 30 Dist. Hex 4.36 4.24 4.94 118 113 312 21.6 — —
Albumin/PEG 20 Dist. Hex 4.25 4.21 4.88 119 183 399 20.7 4.57 5.28
Albumin/PEG 30 Hexagonal 4.19 — 4.84 120 494 — 20.3 — —
Albumin/PEG 40 Hexagonal 4.18 — 4.83 120 280 — 20.2 4.33 5.00
Values are calculated from peak positions of the in-plane scattering vector component qxy from peak fits using a Lorentzian model. Phase 1 is the dominant
phase and transitions from a distorted hexagonal lattice (a ¼ b, as 120) to a hexagonal lattice (a ¼ b, a ¼ 120) with increasing surface pressure. Phase 2
d-spacings are given only for experiments in which the signal is above the background. The phase 2 lattice is assumed to be hexagonal.
*First row for a PEG subphase at 40 mN/m is 200 mg Survanta, and the second is 600 mg.profiles for Survanta (Fig. 5 b), r/rsub is significantly greater
than one for 50 < z < 100 A˚. The error (c2) of the fit of the
XR data on the albumin subphase increased significantly
when the length of the electron density profile was reduced
from z ¼ 140 A˚. A Fourier transform of the XR data (see
the Supporting Material) shows peaks above the noise at
FIGURE 4 Bragg peaks from GIXD of 600 mg Survanta spread onto
a subphase containing 2 mg/mL albumin and 5% wt. PEG at 20–40 mN/m.
The packing changes from distorted hexagonal to hexagonal at a lower
surface pressure than Survanta on the control subphase. The hexagonal
lattice with zero tilt occurs at a lower surface pressure than on the control
subphase (Fig. 1).z ~ 50 A˚ and 85 A˚, suggesting a second layer of albumin,
which is a prolate spheroid of dimensions 40  40 
140 A˚ (30). Both neutron reflectivity (30) and ellipsometry
(31) of albumin at the air-water interface also indicate
a dense, closely packed monolayer followed by a less dense
second layer. Our XR data indicate two layers with the
albumin long axis parallel to the interface. Other globular
proteins, such as b-lactoglobulin, have a similar maximum
electron density (r/rsub ¼ 1.20) (32).
The electron density (Fig. 6 b) in regions 1 and 2 (defined
in Fig. 3) is qualitatively similar to that of albumin, even
though GIXD showed small patches of ordered Survanta in
region 2. However, the electron density of the mixed Sur-
vanta/albumin films in both regions 1 and 2 decreased
more quickly with increasing z than the albumin film. This
suggests that Survanta has displaced the second layer of
albumin. In contrast, the electron density of the mixed Sur-
vanta-albumin film at 28 mN/m, the highest surface pressure
that can be sustained for the duration of the XR experiment,
overlays that of Survanta on the control buffer at 30 mN/m.
The GIXD curve of Survanta-albumin at 28 mN/m (Fig. 4)
shows diffraction peaks, confirming that Survanta is at the
interface. The ratio of Survanta to albumin at the interface
apparently increases with increasing surface pressure.
However, the film is still ‘‘inhibited’’ by albumin; isotherms
(Supporting Material) show that the maximum surface pres-
sure does not increase above 35 mN/m even after compres-
sion to the smallest trough area, suggesting that the Survanta
never completely displaces the albumin.
Fig. 7, a and b, show the XR and electron density profiles
for low (200 mg) and high (600 mg) concentrations of
Survanta spread on a subphase containing 5% wt. PEG atBiophysical Journal 97(3) 777–786
782 Stenger et al.40 mN/m. PEG increases the subphase electron density ~6%
and this value (rsub ¼ 0.353 e/A˚3) was used for all XR fits.
Fig. 7 b shows that r/rsub is less than unity for the PEG-con-
taining subphase over the entire range of z, with a minimum
value of 0.98. This suggests that the PEG concentration near
the interface is below that of the bulk, consistent with a PEG
‘‘depletion layer’’ at the interface (4). The r/rsub values for
FIGURE 5 (a) XR for 200 mg Survanta spread on the control subphase.
The blue lines are fits to the data using a model-independent algorithm as
discussed in the text. (b) The electron density profiles, normalized by the
subphase electron density, for the corresponding XR data. With increasing
surface pressure, the headgroup maximum increases, the width of the head-
group region decreases, and the location of the headgroup maximum shifts to
the right.Biophysical Journal 97(3) 777–786both low (200 mg) and high (600 mg) Survanta concentra-
tions on the PEG subphase at 40 mN/m are identical; the
electron density reaches a maximum of r/rsub ¼ 1.11. The
agreement between the XR curves at different concentrations
is consistent with the GIXD results (Table 1), which shows
that both the lateral and vertical surfactant organizations
FIGURE 6 (a) XR for 600 mg Survanta spread on a saline buffer subphase
containing 2 mg/mL albumin. No Survanta is present for the albumin
subphase data. Regions 1 and 2 are the same areas used for the GIXD in
Fig. 4. (b) The electron density profiles, normalized by the subphase electron
density. For Survanta-albumin-20 mN/m, the electron density profile is
similar to that of albumin for both regions 1 and 2, whereas at 28 mN/m
the electron density profile is similar to that of Survanta (Fig. 6).
GIXD/XR Study of Surfactant Inhibition and Reversal 783are independent of subphase concentration. The electron
density at the interface drops below unity for both concentra-
tions, reaching a minimum value of 0.95 for the high concen-
tration, which is also consistent with a PEG depletion layer.
The maximum in r/rsub corresponding to the headgroups,
and the inflection at z ~ 19 A˚ corresponding to the tailgroups
are reduced on the PEG subphase compared to the control
buffer; the headgroup maximum r/rsub decreases from
1.22 to 1.11, and the tailgroup r/rsub decreases from 0.96
to 0.82.
Fig. 8, a and b, show the XR and electron density profiles
for Survanta spread on a subphase containing both 2 mg/mL
albumin and 5% wt. PEG. The albumin-PEG subphase has
FIGURE 7 (a) XR for 200 mg and 600 mg of Survanta spread on a saline
buffer subphase containing 5% wt. PEG at 40 mN/m. No Survanta is present
for the PEG subphase data. (b) The electron density profiles, normalized by
the subphase electron density. The two Survanta concentrations result in
nearly identical density profiles. The electron density profile of 200 mg Sur-
vanta on the control subphase at 40 mN/m is shown for comparison.an electron density profile similar to that of albumin
(Fig. 6), with a maximum electron density of r/rsub ¼ 1.18
at z ¼ 15 A˚. However, the albumin-PEG subphase profile
decreases more quickly than albumin and reaches a minimum
value of 0.95, again consistent with a PEG depletion layer.
FIGURE 8 (a) XR for 600 mg Survanta spread on a subphase containing
2 mg/mL albumin and 5% wt. PEG. No Survanta is present for the albumin-
PEG subphase data. (b) The electron density profiles normalized by the
subphase electron density. At 20 mN/m, the electron density profile is
similar to that of albumin, whereas for 30 and 40 mN/m, the electron density
is similar to that of Survanta, indicating that Survanta has displaced the
albumin. The electron density profile of 200 mg Survanta on the control
subphase at 40 mN/m is shown for comparison.Biophysical Journal 97(3) 777–786
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electron density profile is qualitatively similar to that of
albumin for z < 50 A˚, indicating that the interfacial film
within the beam footprint is dominated by albumin.
However, GIXD for the same film at 20 mN/m (Fig. 4)
shows diffraction peaks, indicating that some ordered Sur-
vanta coexists at the interface. The Survanta-albumin-PEG
20 mN/m electron density profile decreases less quickly
than that for the albumin-PEG subphase; for z > 50 A˚, it
overlaps with the Survanta electron density profile. For Sur-
vanta-albumin-PEG at 30 mN/m and 40 mN/m, the electron
density profiles are more similar to that of Survanta on the
control subphase, indicating that at higher surface pressures,
Survanta has displaced albumin from the interface. However,
r/rsub > 1 at larger z, which may be due to albumin remain-
ing near the interface. The magnitude of this effect may be
masked by the PEG depletion layer. Overall, when PEG
and albumin are in the subphase, XR and GIXD show that
the Survanta displaces albumin from the subphase as the
surface pressure increases.
DISCUSSION
Table 1 summarizes the area per hydrocarbon chain of the
in-plane ordered fraction of Survanta as a function of
subphase composition and surface pressure. The projected
area per chain normal to the interface decreases with
increasing surface pressure for all subphases. The area/mole-
cule for the control interface changes from 21.7 A˚2 at 20 mN/
m to 20.3 A˚2 at 50 mN/m, primarily due to the decreasing
molecular tilt. GIXD shows that when Survanta coexists
with albumin at the interface without PEG in the subphase,
the area per chain increases to 22.8 A˚2 at 20 mN/m. Albumin
seems to lower the effective surface pressure, allowing the
Survanta lattice to tilt more than on the control subphase.
On the other hand, PEG compacts the Survanta lattice; the
area per chain decreases from 21.7 A˚2 (control) to 20.7 A˚2
(albumin-PEG) at 20 mN/m, again by decreasing the molec-
ular tilt. By 40 mN/m, the lattice is hexagonal and the mole-
cules are untilted on all subphases, and the area per chain on
the albumin-PEG subphase is identical to the PEG subphase
(20.2 A˚2), and only slightly less than on the control subphase
(20.5 A˚2). At low surface pressures, where the molecules are
tilted, PEG and albumin together in the subphase have the
same effect on Survanta as increasing the surface pressure
by ~10 mN/m; albumin alone has the same effect as
decreasing the surface pressure by ~5 mN/m. Once the mole-
cules are normal to the interface, there is less change in the
area/molecule by PEG or albumin, or by further increases
in the surface pressure.
The lattice spacing and tilt of the main diffraction peaks
and their evolution with surface pressure are consistent
with the ordered domains of Survanta being composed of
DPPC (~70% wt.) and the PA that is added to the bovine
extract (PA ~10% wt.) (17,24–26). Previous work has shownBiophysical Journal 97(3) 777–786that the unsaturated lipids along with the SP-B and SP-C
proteins separate into the disordered phases and hence do
not contribute to the diffraction peaks (25,33–35). GIXD
of a DPPC/POPG/PA (69/20.5/10 wt.) lipid mixture on
a pure water subphase shows that the lattice changes from
tilted, oblique lattice at 25 mN/m with d10 ¼ 4.38 A˚,
d01 ¼ 4.30 A˚, and d11 ¼ 4.23 A˚ to a simple hexagonal lattice
at 50 mN/m with d10¼ 4.17 A˚ (25). For the DPPC/POPG/PA
mixture, the tilt is reduced from 19 at 25 mN/m to 0 at
50 mN/m. Survanta has a tilted, distorted hexagonal lattice
with d10 ¼ 4.38 A˚ and d11 ¼ 4.24 A˚ at 20 mN/m, and
compacts to an untilted hexagonal lattice with d10 ¼ 4.19 A˚
at 50 mN/m. The similarity between the evolution of the
molecular organization with surface pressure and the details
of the lattice spacing of the simple lipid mixtures suggest that
the solid phase in Survanta is composed mainly of DPPC and
PA (26). The presence of a second, minor crystalline phase in
Survanta is not unexpected in a complex mixture; our
previous limited GIXD study on Survanta also showed two
phases (26).
Albumin has similar effects on the Survanta film as Polox-
amer 188 (P188), a triblock copolymer with a polyethylene
oxide-polypropylene oxide-polyethylene oxide structure
(molecular weight: 8400) has onDPPC (29,36). Both albumin
and P188 are water-soluble and surface-active (29,36). At
30 mN/m, the Bragg peaks for DPPC (q10¼ 1.38 A˚1, q11¼
1.46 A˚1) and DPPC/P188 (q10¼ 1.37 A˚1, q11¼ 1.46 A˚1)
monolayers are nearly identical. P188 is squeezed out of the
interfacial film at surface pressures of 35–40 mN/m, which
is ~15 mN/m above its equilibrium surface pressure. At pres-
sures below 35–40 mN/m, XR shows a heterogeneous film
that contains P188-rich and DPPC-rich regions; above
40 mN/m, GIXD shows that the film is identical to DPPC.
In contrast, at 28 mN/m, the Bragg peaks for Survanta on an
albumin subphase (q10 ¼ 1.44 A˚1, q11 ¼ 1.48 A˚1) are
slightly shifted compared to Survanta on the control subphase
at 30 mN/m (q10¼ 1.47 A˚1, q11¼ 1.49 A˚1), with a similar
trend at 20 mN/m. XR shows that albumin and Survanta
coexist on an albumin-containing subphase, with a gradual
transition from albumin-rich at low surface pressure to Sur-
vanta-rich at higher surface pressures. Fluorescence images
show that patches of albumin can coexist with Survanta at
surface pressures as high as 55–60 mN/m (5–7). This is
significantly higher than the albumin equilibrium surface
pressure of 18 mN/m; albumin deviates significantly from
ideal Gibbs monolayer behavior despite its molecular solu-
bility. Albumin, unlike P188, has secondary and tertiary struc-
tures that can denature at the interface, which is likely the
origin of this nonideal behavior at the interface (31). Although
the primary effect of the albumin is to inhibit Survanta from
reaching the interface, albumin also acts to lower the effective
surface pressure at the interface, resulting in a less-compact,
less-ordered Survanta film.
When PEG and albumin are present together in the
subphase at 20 mN/m, GIXD shows diffraction peaks,
GIXD/XR Study of Surfactant Inhibition and Reversal 785whereas XR shows an electron density similar to that of
albumin, indicating that the interface is albumin-rich.
However, albumin is displaced from the interface at higher
surface pressures; at 30 and 40 mN/m, GIXD shows Survanta
peaks, whereas XR shows a Survanta-like average electron
density. This heterogeneity of the Survanta-albumin interface
on the scale of the x-ray footprint is consistent with previous
fluorescence images of the interface (5–7). Only when suffi-
cient Survanta adsorbs to the interface at low surface pre-
ssures can the film achieve sufficiently high surface pressure
on compression to ‘‘squeeze out’’ the albumin. These images
show that under dynamic compression, some albumin
remains up to a surface pressure as high as 55–60 mN/m.
Themeasured electron density shows that the PEG concentra-
tion is lower at the interface than in the bulk, forming a ‘‘deple-
tion layer’’, which is one of the requirements for a ‘‘depletion
attraction’’ (4,6). PEG in the subphase compacts the Survanta
lattice and eliminates themolecular tilt at a lower surface pres-
sure compared to the control subphase. It may be that PEG
induces a lateral ‘‘depletion attraction’’ within the film, as
well as a depletion attraction that forces Survanta to the inter-
face (37). More detailed GIXD measurements, especially on
tilted and compressible monolayers as a function of PEG
concentration, are needed to address this issue.
CONCLUSIONS
With increasing surface pressure, Survanta on a saline
subphase, on a subphase with albumin, or on a subphase
with albumin andPEGundergoes a transition fromadistorted,
tilted hexagonal lattice to an untilted hexagonal latticewith in-
creasing surface pressure, in similarity to DPPC and DPPC/
PA mixtures (24–27,36). XR confirms these results: the
maximum in electron density associated with the headgroup
increases, the width of the headgroup region decreases, and
the location of the headgroup maximum indicates a reduction
in the tilt of the monolayer with increasing surface pressure.
Adding 2 mg/mL albumin to the subphase inhibits Sur-
vanta adsorption to the interface indefinitely; only a small
fraction of the interface shows Survanta diffraction peaks
at 20 mN/m and the XR data show that the average electron
density of the interface is that of albumin. The Survanta
patches that do coexist with albumin have a larger lattice
spacing and greater molecular tilt than on the control inter-
face. Adding PEG to the albumin subphase restores the char-
acteristic Survanta isotherms, and XR shows an average
electron density similar to that of Survanta on the control
subphase. The characteristic Survanta Bragg peaks are
restored in the Survanta/albumin/PEG system, but with
a slightly more compact lattice that undergoes the distorted
hexagonal to hexagonal transition at a lower surface pres-
sure. XR also shows that the PEG concentration is lower at
the interface than in the bulk. This PEG depletion layer is
consistent with the proposed depletion attraction/energy
barrier model proposed to reverse LS inhibition (4). Ourresults confirm that negatively charged albumin at the inter-
face inhibits adsorption of the negatively charged LS due to
a combination of electrostatic and steric repulsion, analo-
gously to the energy barriers that prevent colloid flocculation
(4). Adding PEG induces a depletion attraction between the
multimicron LS liposomes and the interface that decreases
this repulsive energy barrier, leading to more Survanta
reaching the interface. This increased LS adsorption then is
capable of displacing albumin and maintaining higher
surface pressures. Although this energy barrier-depletion
attraction model has been used to explain isotherms, fluores-
cence microscopy images, and the scaling of adsorption with
PEG concentration and molecular weight (6,7), the GIXD
and XR data presented here directly show the three-dimen-
sional distribution of albumin, PEG, and LS, confirming
the molecular mechanisms of the model.
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